Dr. Mark Pruzanski is a physician and entrepreneur with more than 30 years of experience in the life sciences. Most recently he served as Chairman and Chief Executive Officer of Versanis Bio where he spearheaded the development of novel therapies for obesity and other cardiometabolic diseases until the company’s acquisition in 2023 by Eli Lilly […]
Renée Aguiar-Lucander is CEO of Hansa Biopharma as of April 2025. She was previously CEO of Calliditas Therapeutics, where she led the transformation of the company from a small biotech into a NASDAQ-listed, commercial-stage leader in rare diseases, culminating in its $1.1 billion acquisition by Asahi Kasei in 2024. Under her leadership, Calliditas achieved the […]
Dr. Srinivas Akkaraju is the Founder and Managing General Partner of Samsara BioCapital. Before establishing Samsara, he served as a General Partner at Sofinnova Ventures from 2013 to 2016, and as Managing Director at New Leaf Venture Partners from 2009 to 2013. Dr. Akkaraju also held the position of Managing Director at Panorama Capital, LLC, […]
Heinz Maeusli has been a member of our Board of Directors since 2019. Before joining our Board of Directors, Mr. Maeusli was Chief Financial Officer of Advanced Accelerator Applications (AAA) from 2003 to 2018, where he was instrumental in making this company a leader in the sector of nuclear medicine. In this capacity, he led […]
Annick Schwebig has served as a member of our Board of Directors since February 2017. Mrs. Schwebig was the founder and Chief Executive Officer of Actelion Pharmaceuticals France from 2000 to 2015, a laboratory specializing in the development of drugs for orphan diseases. She has held senior positions in the pharmaceutical industry as Vice-President of […]
André Turenne has more than 20 years of global experience in the pharmaceutical industry. He is currently President and Chief Executive Officer of the Boston-based biotech Matchpoint Therapeutics, and Advisor to Atlas Venture since 2021. Prior to joining Matchpoint, André Turenne served as President and Chief Executive Officer of Voyager Therapeutics. He previously held senior […]
